SCHEMBL5589013

SCHEMBL5589013

CCC(CC)(CC)c1cccc(O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CA2 P00918 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CA1 P00915 2/20 0.46
ADAMTS4 O75173 1/20 0.46
EGFR P00533 1/20 0.46
FYN P06241 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
CA6 P23280 1/20 0.46
CDK2 P24941 1/20 0.46
MMP12 P39900 1/20 0.46
RECQL P46063 1/20 0.46
ADAMTS5 Q9UNA0 1/20 0.46
TRPA1 O75762 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588179 0.88 ALDH1A1 (0.39) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL27734961 0.85 ALDH1A1 (0.37) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL5590000 0.85 IAPP (0.40) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL10921220 0.85 CA2 (0.46) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL27533189 0.84 ALDH1A1 (0.35) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL8956484 0.83 ALDH1A1 (0.46) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL31276573 0.82 TSHR (0.56) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL980707 0.82 TSHR (0.56) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL10849701 0.81 CA2 (0.46) ALDH1A1CA2TDP1LMNAHPGD
SCHEMBL4493446 0.81 CA2 (0.46) ALDH1A1CA2TDP1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101541854-A Branched polycarbonate resins and processes to prepare the same SABIC INNOVATIVE PLASTICS IP (NL) 2009-09-23 CN claimed
CN-101541854-A Branched polycarbonate resins and processes to prepare the same SABIC INNOVATIVE PLASTICS IP (NL) 2009-09-23 CN disclosed
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed
US-4511457-A N,N*-PHENOTHIAZINE DIMER, TERT-ALKYL CATECHOL OR HYDROQUINONE ATLANTIC RICHFIELD COMPANY (US) 1985-04-16 US disclosed
US-4487981-A ADDING N,N' DIMER OF PHENOTHIAZINE AND AN ALKYL CATECHOL OR ALKYL HYDROQUINONE ATLANTIC RICHFIELD COMPANY (US) 1984-12-11 US disclosed
US-4434307-A N,N-DIARYLHYDROXYLAMINE, MONO-OR DI-TERT-BUTYL CATECHOL OR HYDROQUINONE ATLANTIC RICHFIELD COMPANY (US) 1984-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALDH1A1 2181/4885CA2 2455/4885TDP1 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.